Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory Systemic Lupus Erythematosus”

151 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 151 results

Not applicableNot Yet RecruitingNCT07083349
What this trial is testing

NK510 Cell Therapy for Refractory Systemic Lupus Erythematosus

Who this might be right for
Refractory Systemic Lupus Erythematosus
Base Therapeutics (Shanghai) Co., Ltd. 9
Early research (Phase 1)Looking for participantsNCT06349343
What this trial is testing

CD19/BCMA CAR-T Cell Therapy for Refractory/Moderate-to-severe Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 20
Testing effectiveness (Phase 2)Looking for participantsNCT06585514
What this trial is testing

Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus (SLE)Lupus Nephritis (LN)
Beijing GoBroad Hospital 18
Early research (Phase 1)Looking for participantsNCT06530849
What this trial is testing

GC012F Injection in Subjects With Refractory Systemic Lupus Erythematosus

Who this might be right for
Refractory Systemic Lupus Erythematosus
Gracell Biotechnologies (Shanghai) Co., Ltd. 18
Not applicableStudy completedNCT03828071
What this trial is testing

Autologous Hematopoietic Stem Cell Transplantation for Refractory Lupus Nephritis

Who this might be right for
Lupus Nephritis
Nanjing University School of Medicine 22
Early research (Phase 1)Not Yet RecruitingNCT06468683
What this trial is testing

F01 in the Treatment of Moderate-to-severe Refractory Systemic Lupus Erythematosus

Who this might be right for
Lupus Erythematosis
Shanghai Simnova Biotechnology Co.,Ltd. 50
Not applicableLooking for participantsNCT06503224
What this trial is testing

An Exploratory Clinical Study of SCAR02 Targeting BCMA and CD19 for the Treatment of Refractory Autoimmune Diseases

Who this might be right for
Autoimmune Diseases
The First Affiliated Hospital of University of Science and Technology of China 18
Very early researchLooking for participantsNCT06653556
What this trial is testing

LCAR-AIO in Subjects With Relapsed/Refractory Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus (SLE)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 34
Very early researchLooking for participantsNCT06010472
What this trial is testing

An Exploratory Clinical Study of Anti-CD19 CAR NK Cells in the Treatment of Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus (SLE)
Changhai Hospital 36
Testing effectiveness (Phase 2)Looking for participantsNCT06428188
What this trial is testing

Sequential CAR-T Cells Targeting BCMA/CD19 in Patients With Relapsed/ Refractory Autoimmune Diseases

Who this might be right for
Autoimmune DiseasesSystemic Lupus ErythematosusSystemic Lupus Erythematosus Acute+1 more
Essen Biotech 60
Not applicableLooking for participantsNCT06277427
What this trial is testing

Refractory ANCA Associated Vasculitis and Lupus Nephritis Treated With BCMA-targeting CAR-T Cells

Who this might be right for
Lupus NephritisANCA Associated Vasculitis
Lingli Dong 24
Testing effectiveness (Phase 2)WithdrawnNCT06153095
What this trial is testing

IMPT-514 in Active Refractory Lupus Nephritis (LN) and Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus ErythematosusLupus Nephritis
Lyell Immunopharma, Inc.
Not applicableLooking for participantsNCT07121777
What this trial is testing

Anti CD19/BCMA CAR Gene Therapy for Autoimmune Diseases

Who this might be right for
Autoimmune Diseases
Anhui Provincial Hospital 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT06342960
What this trial is testing

KYSA-3: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis

Who this might be right for
Lupus NephritisLupus Nephritis - WHO Class IIILupus Nephritis - WHO Class IV
Kyverna Therapeutics 2
Early research (Phase 1)Looking for participantsNCT06978647
What this trial is testing

A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases

Who this might be right for
Systemic Lupus Erythematosus (SLE)Systemic Sclerosis (SSc)Inflammatory Myopathy+5 more
China Immunotech (Beijing) Biotechnology Co., Ltd. 12
Early research (Phase 1)Looking for participantsNCT06934447
What this trial is testing

Study of BCMA/CD70 CAR-T Therapy for Refractory cSLE

Who this might be right for
CAR T Cell TherapySystemic Lupus ErythematosusBCMA
The Children's Hospital of Zhejiang University School of Medicine 18
Very early researchWithdrawnNCT06866080
What this trial is testing

LCAR-AIO in Subjects With Relapsed/Refractory Autoimmune Diseases

Who this might be right for
Relapsed/Refractory Autoimmune Diseases
Nanjing Legend Biotech Co.
Testing effectiveness (Phase 2)Looking for participantsNCT06947460
What this trial is testing

CD19-BCMA CART Cell Therapy for Refractory SLE-LN, SSc, and pSS-PAH

Who this might be right for
Refractory Lupus NephritisSystemic SclerosisPrimary Sjogren's Syndrome Combined With Pulmonary Hypertension
Beijing GoBroad Hospital 45
Early research (Phase 1)Not Yet RecruitingNCT06708845
What this trial is testing

US Zamto-cel Autoimmune Diseases

Who this might be right for
Lupus NephritisSystemic Lupus ErythematosusSystemic Sclerosis (SSc)+1 more
Miltenyi Biomedicine GmbH 48
Early research (Phase 1)Looking for participantsNCT06316076
What this trial is testing

Safety and Efficacy Study of CD19-CAR-DNT Cells in Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusAnti-Neutrophil Cytoplasmic Antibody-Associated VasculitisIdiopathic Inflammatory Myopathies+1 more
RenJi Hospital 48
Load More Results